SYK Stryker Corporation
SYK Stryker Corporation
Healthcare · Medical Devices
Market read
Scan convergence 1 scan as of 2026-08-14 1 bear converging
POC $362.36 · VWAP $341.09 · -2.8% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
2 watchlists
SYK Price Structure
Loading timeframes…
Peers
Every watchlist SYK belongs to, members best 30-day change first — SYK highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@healthcare-scan
@healthcare
Decision history
2 scored calls · newest first · projection
How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.
Reported the quarter ending 2026-03-31: revenue $6.02B, diluted EPS $1.93, net income $745M (SEC filing). Across the print the stock moved -6.5% (close before → first close after).
full note →Against street estimates
How SYK's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about SYK from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 34 days ago · Jul 15
- Stryker Transcript: Bank of America Global Healthcare Conference 2026
- How Investors May Respond To Stryker (SYK) Cyber Disruption ...
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
SYK research tape
39 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.